Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus (Q37728774)

From Wikidata

Jump to navigation Jump to search

scientific article published on 17 March 2010

Language	Label	Description	Also known as
English	Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus	scientific article published on 17 March 2010

Statements

scholarly article

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

Asymmetric dimethylarginine as a mediator of vascular dysfunction and a marker of cardiovascular disease and mortality: an intriguing interaction with diabetes mellitus (English)

1 reference

Europe PubMed Central

22 August 2017

cardiovascular disease

1 reference

based on heuristic

inferred from title

Edzard Schwedhelm

2

object named as

Edzard Schwedhelm

1 reference

Europe PubMed Central

22 August 2017

Ramachandran S. Vasan

object named as

Ramachandran S Vasan

4

0 references

author name string

Maike Anderssohn

1

1 reference

Europe PubMed Central

22 August 2017

Nicole Lüneburg

3

1 reference

Europe PubMed Central

22 August 2017

Rainer H Böger

5

1 reference

Europe PubMed Central

22 August 2017

language of work or name

0 references

publication date

17 March 2010

1 reference

Europe PubMed Central

22 August 2017

Diabetes and Vascular Disease Research

1 reference

Europe PubMed Central

22 August 2017

7

1 reference

Europe PubMed Central

22 August 2017

2

1 reference

Europe PubMed Central

22 August 2017

105-118

1 reference

Europe PubMed Central

22 August 2017

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The Role of Endothelium in the Responses of Vascular Smooth Muscle to Drugs

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The L-arginine-nitric oxide pathway: role in atherosclerosis and therapeutic implications

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

A common variant of endothelial nitric oxide synthase (Glu298Asp) is an independent risk factor for carotid atherosclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Low basal and stimulated release of nitric oxide in atherosclerotic epicardial coronary arteries

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The clinical pharmacology of L-arginine

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Purification and characterization of the constitutive nitric oxide synthase from human placenta

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Identification of two human dimethylarginine dimethylaminohydrolases with distinct tissue distributions and homology with microbial arginine deiminases

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Atherosclerosis impairs endothelium-dependent vascular relaxation to acetylcholine and thrombin in primates

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Impairment of endothelium-dependent relaxation in aortae from spontaneously diabetic rats

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Relation of plasma glucose and endothelial function in a population-based multiethnic sample of subjects without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Microvascular function relates to insulin sensitivity and blood pressure in normal subjects

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

A study of endothelial function and circulating asymmetric dimethylarginine levels in people with Type 1 diabetes without macrovascular disease or microalbuminuria

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Obesity/insulin resistance is associated with endothelial dysfunction. Implications for the syndrome of insulin resistance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endothelial dysfunction in impaired fasting glycemia, impaired glucose tolerance, and type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Flow-mediated vasoactivity and circulating adhesion molecules in hypertriglyceridemia: association with small, dense LDL cholesterol particles.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Intravenous intralipid-induced blood pressure elevation and endothelial dysfunction in obese African-Americans with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Insulin causes endothelial dysfunction in humans: sites and mechanisms.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Additional contribution of emerging risk factors to the prediction of the risk of type 2 diabetes: evidence from the Western New York Study

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Microvascular recruitment is an early insulin effect that regulates skeletal muscle glucose uptake in vivo

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Modulation of regional nitric oxide metabolism: blood glucose control or insulin?

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Arginine metabolism: nitric oxide and beyond

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Disruption of methylarginine metabolism impairs vascular homeostasis

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Vascular endothelial-specific dimethylarginine dimethylaminohydrolase-1-deficient mice reveal that vascular endothelium plays an important role in removing asymmetric dimethylarginine

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Extensive characterization of the human DDAH1 transgenic mice

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Overexpression of dimethylarginine dimethylaminohydrolase inhibits asymmetric dimethylarginine-induced endothelial dysfunction in the cerebral circulation.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortality.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Impact of asymmetric dimethylarginine on mortality after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma levels of asymmetrical dimethylarginine and adverse cardiovascular events after percutaneous coronary intervention

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene Study

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study).

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine enhances cardiovascular risk prediction in patients with chronic heart failure.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine (ADMA): a novel risk marker in cardiovascular medicine and beyond

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Risk of acute coronary events and serum concentration of asymmetrical dimethylarginine

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine, smoking, and risk of coronary heart disease in apparently healthy men: prospective analysis from the population-based Monitoring of Trends and Determinants in Cardiovascular Disease/Kooperative Gesundheitsforschung in de

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in Gothenburg

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Vascular reactivity

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Uncomplicated type 1 diabetes is associated with increased asymmetric dimethylarginine concentrations.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevated plasma asymmetric dimethylarginine as a marker of cardiovascular morbidity in early diabetic nephropathy in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Relationship between insulin resistance and an endogenous nitric oxide synthase inhibitor

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma asymmetric dimethylarginine concentrations are elevated in obese insulin-resistant women and fall with weight loss

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Circulating concentrations of asymmetrical dimethyl-L-arginine are increased in women with previous gestational diabetes.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Glycemic control modulates arginine and asymmetrical-dimethylarginine levels during critical illness by preserving dimethylarginine-dimethylaminohydrolase activity

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Effect of acute variations of insulin and glucose on plasma concentrations of asymmetric dimethylarginine in young people with Type 1 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevated plasma adiponectin and decreased plasma homocysteine and asymmetric dimethylarginine in children with type 1 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Increased levels of asymmetric dimethylarginine in populations at risk for atherosclerotic disease. Effects of pravastatin

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Regular physical exercise normalizes elevated asymmetrical dimethylarginine concentrations in patients with type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Decreased levels of asymmetric dimethylarginine during acute hyperinsulinemia.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevations of plasma methylarginines in obesity and ageing are related to insulin sensitivity and rates of protein turnover

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Circulating asymmetric dimethylarginine, endothelin-1 and cell adhesion molecules in women with gestational diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Elevated concentrations of asymmetric dimethylarginine are associated with deterioration of glucose tolerance in women with previous gestational diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine is closely associated with the development and progression of nephropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Angiotensin-converting enzyme activity is involved in the mechanism of increased endogenous nitric oxide synthase inhibitor in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Metformin treatment lowers asymmetric dimethylarginine concentrations in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma concentrations of asymmetric dimethylarginine are increased in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Plasma concentrations of asymmetric-dimethyl-arginine in type 2 diabetes associate with glycemic control and glomerular filtration rate but not with risk factors of vasculopathy

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Effect of diabetic duration on serum concentrations of endogenous inhibitor of nitric oxide synthase in patients and rats with diabetes

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

The relationship between plasma asymmetrical dimethyl-L-arginine and inflammation and adhesion molecule levels in subjects with normal, impaired, and diabetic glucose tolerance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine, cortisol/cortisone ratio, and C-peptide: markers for diabetes and cardiovascular risk?

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

High serum TNF-alpha level in Type 2 diabetic patients with microangiopathy is associated with eNOS down-regulation and apoptosis in endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Intensive treatment of risk factors in patients with type-2 diabetes mellitus is associated with improvement of endothelial function coupled with a reduction in the levels of plasma asymmetric dimethylarginine and endogenous inhibitor of nitric oxid

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Modulation of asymmetric dimethylarginine in critically ill patients receiving intensive insulin treatment: a possible explanation of reduced morbidity and mortality?

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Reduced nitric oxide concentration in the renal cortex of streptozotocin-induced diabetic rats: effects on renal oxygenation and microcirculation

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Oxidation of tetrahydrobiopterin leads to uncoupling of endothelial cell nitric oxide synthase in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Arginase inhibition restores NOS coupling and reverses endothelial dysfunction and vascular stiffness in old rats.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Asymmetric dimethylarginine (ADMA) and other endogenous nitric oxide synthase (NOS) inhibitors as an important cause of vascular insulin resistance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Effects of antioxidant supplementation on postprandial oxidative stress and endothelial dysfunction: a single-blind, 15-day clinical trial in patients with untreated type 2 diabetes, subjects with impaired glucose tolerance, and healthy controls.

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Nitrosative stress and pathogenesis of insulin resistance

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Endothelial dysfunction: the first step toward coronary arteriosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1479164110366053

21 January 2018

Identifiers

10.1177/1479164110366053

1 reference

Europe PubMed Central

22 August 2017

1 reference

Europe PubMed Central

22 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37728774&oldid=2092629145"